A Scottish scorecard to assess cardiovascular risk can shift preventative treatment to more socially deprived groups, according to a new study.
Researchers tested the ASSIGN scorecard on 13,297 randomly-sampled individuals aged 30 to 74 and initially free from cardiovascular disease.
They concluded that ASSIGN does not have a greater specificity or sensitivity than the Framingham scorecard, which is conventionally used to assess cardiovascular risk.
However, it does redistribute higher risk scores, and therefore preventative treatment, towards more socially deprived groups.
Other variations on Framingham include introducing family history and a quantification of cigarette smoking.
Heart. Published online. Doi:10.1136/hrt.2006.108167